Your browser doesn't support javascript.
loading
Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval.
Ciruelos, Eva; Alba, Emilio; López, Rafael; Lluch, Anna; Martín, Miguel; Arroyo, Isabel; Navarro, Beatriz; Carcedo, David; Colomer, Ramón; Albanell, Joan.
Afiliação
  • Ciruelos E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Alba E; Clinical Oncology Unit, Hospitales Universitarios Regional y Virgen de la Victoria; Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain.
  • López R; Department of Medical Oncology, Hospital Clínico Universitario e Instituto de Investigación Sanitaria-CIBERONC, Santiago de Compostela, Spain.
  • Lluch A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Health Research Institute INCLIVA, University of Valencia, The Centre of Networked Biomedical Cancer Research (CIBERONC), Valencia, Spain.
  • Martín M; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, GEICAM, CIBERONC, Madrid, Spain.
  • Arroyo I; Department of Payer Evidence and Health Economics, Roche Pharma, Madrid, Spain.
  • Navarro B; Medical Department, Roche Pharma, Madrid, Spain.
  • Carcedo D; Oblikue Consulting, Barcelona, Spain.
  • Colomer R; Medical Oncology Service, Hospital Universitario La Princesa, Madrid, Spain.
  • Albanell J; Medical Oncology Service, Hospital del Mar, IMIM, Universitat Pompeu Fabra, The Centre of Networked Biomedical Cancer Research (CIBERONC), and Centro Oncológico Clara Campal-HM Delfos, Barcelona, Spain.
Oncotarget ; 10(42): 4321-4332, 2019 Jul 02.
Article em En | MEDLINE | ID: mdl-31303965
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article